| 摘要 |
PROBLEM TO BE SOLVED: To provide a proteasome activator in order to enable prevention or treatment of neurodegenerative disease, particularly.SOLUTION: A proteasome activator comprises at least one kind of compound selected from the group consisting of ACA (1'-acetoxychavicol acetate) and a specific ACA analogue. |
